Intervention

M7824

ClinicalTrials.gov intervention label

Clinical trials10
Recruiting2
Common conditions24
Lead sponsors shown3

Clinical trials

10 shown
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate CancerNCT04633252 · 2021-02-23
RECRUITING
PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi SarcomaNCT04303117 · 2020-07-13
RECRUITING
BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)NCT04296942 · 2021-05-04
TERMINATED
Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary MalignanciesNCT04235777 · 2020-07-13
ACTIVE_NOT_RECRUITING
Bioimaging Study of 89Zr-M7824 in NSCLCNCT04297748 · 2020-06-01
TERMINATED
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)NCT03840902 · 2019-04-16
TERMINATED
M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)NCT03840915 · 2019-04-02
COMPLETED
M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)NCT03631706 · 2018-10-01
COMPLETED
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung CancersNCT03554473 · 2018-09-11
COMPLETED
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)NCT03493945 · 2018-05-01
COMPLETED

Common conditions

Non-small Cell Lung Cancer3Advanced Solid Tumor1Bladder Cancer1Breast Cancer1Cancer Of Prostate1Carcinoma, Non-Small-Cell Lung1Carcinoma, Small Cell1Genitourinary Cancer1HER2+ Breast Cancer1Hormone Receptor Negative Breast Cancer1Kaposi Sarcoma1Lung Cancer1Metastatic Breast Cancer1Metastatic Castration-resistant Prostate Cancer1Non-metastatic Castration-resistant Prostate Cancer1Prostate Cancer1Prostate Neoplasm1Prostate Neoplasms1Small Cell Lung Cancer1Solid Tumor1Triple Negative Breast Cancer1Urogenital Cancer1Urogenital Neoplasms1Urothelial Cancer1

Trial status mix

COMPLETED4
TERMINATED3
RECRUITING2
ACTIVE_NOT_RECRUITING1

Phase mix

PHASE18
PHASE27
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.